Cargando…
Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD)
The genetic disorder alpha 1 antitrypsin deficiency (AATD) results in reduced levels of alpha 1 antitrypsin (AAT) in the lung and an imbalance between AAT anti-protease activity and the activity of proteases that degrade elastin and connective tissues. This imbalance commonly leads to the excessive...
Autor principal: | Ataya, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718162/ https://www.ncbi.nlm.nih.gov/pubmed/33304809 http://dx.doi.org/10.1016/j.rmcr.2020.101309 |
Ejemplares similares
-
Lung and liver transplantation in patients with alpha-1 antitrypsin
deficiency
por: Zamora, Martin R., et al.
Publicado: (2021) -
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease
por: Guo, Shuling, et al.
Publicado: (2014) -
Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
por: Alí-Munive, Abraham, et al.
Publicado: (2023) -
Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2023) -
Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study
por: Rodríguez Hermosa, Juan Luis, et al.
Publicado: (2023)